109 related articles for article (PubMed ID: 2570971)
1. Treatment of severe premenstrual syndrome with oestradiol patches and cyclical oral norethisterone.
Watson NR; Studd JW; Savvas M; Garnett T; Baber RJ
Lancet; 1989 Sep; 2(8665):730-2. PubMed ID: 2570971
[TBL] [Abstract][Full Text] [Related]
2. Treatment of the premenstrual syndrome by subcutaneous estradiol implants and cyclical oral norethisterone: placebo controlled study.
Magos AL; Brincat M; Studd JW
Br Med J (Clin Res Ed); 1986 Jun; 292(6536):1629-33. PubMed ID: 3087550
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of ovulation with oral progestins--effectiveness in premenstrual syndrome.
West CP
Eur J Obstet Gynecol Reprod Biol; 1990; 34(1-2):119-28. PubMed ID: 2303145
[TBL] [Abstract][Full Text] [Related]
4. The treatment of severe premenstrual syndrome with goserelin with and without 'add-back' estrogen therapy: a placebo-controlled study.
Leather AT; Studd JW; Watson NR; Holland EF
Gynecol Endocrinol; 1999 Feb; 13(1):48-55. PubMed ID: 10368798
[TBL] [Abstract][Full Text] [Related]
5. Treatment of the premenstrual syndrome by subcutaneous oestradiol implants and cyclical oral norethisterone.
Prescott P
Br Med J (Clin Res Ed); 1986 Aug; 293(6544):451. PubMed ID: 3091153
[No Abstract] [Full Text] [Related]
6. The effects of norethisterone in postmenopausal women on oestrogen replacement therapy: a model for the premenstrual syndrome.
Magos AL; Brewster E; Singh R; O'Dowd T; Brincat M; Studd JW
Br J Obstet Gynaecol; 1986 Dec; 93(12):1290-6. PubMed ID: 3801360
[TBL] [Abstract][Full Text] [Related]
7. Transdermal administration of oestrogen/progestagen hormone replacement therapy.
Whitehead MI; Fraser D; Schenkel L; Crook D; Stevenson JC
Lancet; 1990 Feb; 335(8685):310-2. PubMed ID: 1967769
[TBL] [Abstract][Full Text] [Related]
8. Induced anovulation as treatment of premenstrual tension syndrome. A double-blind cross-over study with GnRH-agonist versus placebo.
Hammarbäck S; Bäckström T
Acta Obstet Gynecol Scand; 1988; 67(2):159-66. PubMed ID: 3140572
[TBL] [Abstract][Full Text] [Related]
9. A randomised comparison over 8 months of 100 micrograms and 200 micrograms twice weekly doses of transdermal oestradiol in the treatment of severe premenstrual syndrome.
Smith RN; Studd JW; Zamblera D; Holland EF
Br J Obstet Gynaecol; 1995 Jun; 102(6):475-84. PubMed ID: 7632640
[TBL] [Abstract][Full Text] [Related]
10. Treatment of premenstrual syndrome. A double-blind trial of dydrogesterone.
Dennerstein L; Morse C; Gotts G; Brown J; Smith M; Oats J; Burrows G
J Affect Disord; 1986; 11(3):199-205. PubMed ID: 2951407
[TBL] [Abstract][Full Text] [Related]
11. Pyridoxine (vitamin B6) and the premenstrual syndrome: a randomized crossover trial.
Doll H; Brown S; Thurston A; Vessey M
J R Coll Gen Pract; 1989 Sep; 39(326):364-8. PubMed ID: 2558186
[TBL] [Abstract][Full Text] [Related]
12. Bromocriptine and norethisterone in the treatment of premenstrual syndrome.
Ylöstalo P; Kauppila A; Puolakka J; Rönnberg L; Jänne O
Obstet Gynecol; 1982 Mar; 59(3):292-8. PubMed ID: 6804900
[TBL] [Abstract][Full Text] [Related]
13. Clinical trial of naltrexone in premenstrual syndrome.
Chuong CJ; Coulam CB; Bergstralh EJ; O'Fallon WM; Steinmetz GI
Obstet Gynecol; 1988 Sep; 72(3 Pt 1):332-6. PubMed ID: 3043289
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of the effects of nomegestrol acetate/17 β-estradiol and drospirenone/ethinylestradiol on premenstrual and menstrual symptoms and dysmenorrhea.
Witjes H; Creinin MD; Sundström-Poromaa I; Martin Nguyen A; Korver T
Eur J Contracept Reprod Health Care; 2015; 20(4):296-307. PubMed ID: 25712537
[TBL] [Abstract][Full Text] [Related]
15. Norethisterone enantate in the treatment of premenstrual syndrome.
Gunston KD
S Afr Med J; 1995 Sep; 85(9):851-2. PubMed ID: 8545742
[TBL] [Abstract][Full Text] [Related]
16. Naproxen sodium in the treatment of premenstrual symptoms. A placebo-controlled study.
Facchinetti F; Fioroni L; Sances G; Romano G; Nappi G; Genazzani AR
Gynecol Obstet Invest; 1989; 28(4):205-8. PubMed ID: 2695413
[TBL] [Abstract][Full Text] [Related]
17. Transdermal estradiol/norethisterone. A review of its pharmacological properties and clinical use in postmenopausal women.
Wiseman LR; McTavish D
Drugs Aging; 1994 Mar; 4(3):238-56. PubMed ID: 8199397
[TBL] [Abstract][Full Text] [Related]
18. A double-blind, placebo-controlled evaluation of spironolactone in the premenstrual syndrome.
Vellacott ID; Shroff NE; Pearce MY; Stratford ME; Akbar FA
Curr Med Res Opin; 1987; 10(7):450-6. PubMed ID: 3621990
[TBL] [Abstract][Full Text] [Related]
19. The effect of estradiol and a combined estradiol/progestagen preparation on insulin sensitivity in healthy postmenopausal women.
Duncan AC; Lyall H; Roberts RN; Petrie JR; Perera MJ; Monaghan S; Hart DM; Connell JM; Lumsden MA
J Clin Endocrinol Metab; 1999 Jul; 84(7):2402-7. PubMed ID: 10404811
[TBL] [Abstract][Full Text] [Related]
20. Progesterone and the premenstrual syndrome: a double blind crossover trial.
Dennerstein L; Spencer-Gardner C; Gotts G; Brown JB; Smith MA; Burrows GD
Br Med J (Clin Res Ed); 1985 Jun; 290(6482):1617-21. PubMed ID: 3924191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
